Although long-term nursing home stay or death decreased before the COVID-19 pandemic, the trend slowed during the pandemic ...

The design of the Enhancing Oncology Model (EOM) was a perfect fit for Minnesota Oncology.

Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...

Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments ...

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

First-line maintenance (1LM) niraparib significantly extends progression-free survival (rwPFS) and time to next treatment ...

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 ...

The pause has raised concerns among health officials and state leaders, as the vague wording leaves billions in Medicaid ...

Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, director of pharmacy at Minnesota Oncology, discusses how the prospect of patient ...

The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.